Kadimastem (TASE:KDST) A clinical stage biotech company introducing a cutting-edge TECHNOLOGY PLATFORM for the Development, Manufacturing, and Bio-Banking of functional human cells, providing OFF-THE-SHELF TREATMENT for multiple indications featuring ALS and Type 1 Diabetes as our top two leading projects.
View Top Employees from Kadimastem Ltd.Website | http://www.kadimastem.com |
Ticker | KDST |
Revenue | $197000 |
Employees | 43 (43 on RocketReach) |
Founded | 2009 |
Address | 7 Pinhas Sapir, Ness Ziona, Central District 74140, IL |
Phone | +972 73-797-1600 |
Fax | +972 8-910-0698 |
Technologies |
JavaScript,
HTML,
Twitter
+11 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Therapeutics, Health Care |
Web Rank | 12 Million |
Competitors | Mesoblast Limited, Minerva Biotechnologies, SanBio, StemoniX, ViaCyte |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies |
Looking for a particular Kadimastem Ltd. employee's phone or email?
The Kadimastem Ltd. annual revenue was $197000 in 2024.
Asaf Shiloni is the CEO of Kadimastem Ltd..
43 people are employed at Kadimastem Ltd..
Kadimastem Ltd. is based in Ness Ziona, Central District.
The NAICS codes for Kadimastem Ltd. are [5417, 54, 541, 54171, 541714].
The SIC codes for Kadimastem Ltd. are [873, 87].